Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.0105    0.00 (0.00%)
Bid:
0.009
Ask:
0.012
Spread: 0.003 (33.333%)
Market Cap: £1.64m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Trading Update

13 Feb 2017 07:00

RNS Number : 6694W
Plastics Capital PLC
13 February 2017
Β 

Β 

Β 

Β 

Plastics Capital plc

(The "Company" or the "Group")

Β 

Trading Update

Β 

Plastics Capital plc (AIM: PLA), the niche plastics products group, is pleased to provide a Q3 trading update and to confirm that the Company continues to trade in line with market expectations.

Β 

Group Trading

Group revenues were ahead of expectations in Q3 as a result of stronger than anticipated demand. Gross profit margins remain good but a little lower than historically, due to the changing business mix resulting from the acquisition of Synpac. We have meanwhile increased investment in sales, marketing and new product development across the Group to continue to drive the growth of the business and so profits for the current financial year remain on track to meet market expectations.

Β 

Industrial Division

Bearings and mandrel sales were strong during Q3, supported by new business wins that entered production this financial year and growing demand from US customers. We have also had some excellent new project successes which we expect will enter production in upcoming years and which have replenished the new business pipeline. We are adding sales resources and capacity in both businesses to enable both to meet increasing demand in line with our five year targets.

Β 

Matrix activities continue to make progress in line with our strategy of getting "closer to the customer" and broadening the range of die-cutting and die-making consumables that we have to offer. In December we concluded an agreement with our Italian distributor enabling us to take a significant minority stake in this business which also makes a range of creasing matrix products under the brand name MITO. We have also applied for patents for a new product development being undertaken with one of our Japanese distributors, which we believe has excellent market potential and product trials are ongoing.

Β 

Film Division

The Films Division has had a varied year so far. Flexipol has continued to grow sales and profits, whilst Synpac has traded in line with the expectations that we had formed at the time the acquisition was concluded in July 2016. However, Palagan has experienced some weakness in trading as it made important changes to its business strategy designed to position it for longer term growth.

Β 

At Flexipol we have nearly concluded the installation of an additional extruder which will increase capacity by a third and is expected to enable the business to continue growing at the same rate over the next five years or so. At Synpac we are busy working on procurement and sales synergies with the other companies in the Division, and integrating it into the Group.

Β 

We are currently making important changes within Palagan in terms of its business strategy, which are designed to enable the business to achieve long-term growth. We are investing in the recruitment, training and development of operational staff, the introduction of new films and the development of some innovative products. We anticipate that it will take another 6 -12 months to conclude this transitional phase, at which point Palagan will be in a good position to increase sales and profitability.

Β 

Β 

Commenting, Faisal Rahmatallah, Executive Chairman, said:

Β 

"Trading conditions are generally good and we are busy implementing the investments we have previously highlighted as key to fulfilling the Group's five year strategy. We are very pleased with progress generally across the Group and particularly in our two most substantial business areas, plastic bearings and specialist sacks. Overall, we anticipate that performance over the second half of the financial year will enable us to announce results that are in line with market expectations."

Β 

Β 

Β 

Plastics Capital plc Tel: 020 7978 0574

Faisal Rahmatallah, Executive Chairman

Nick Ball, Finance Director

Β 

Cenkos Securities Tel: 020 7397 8900

Mark Connelly

Callum Davidson

Β 

Allenby Capital Tel: 020 3002 2074

Katrina Perez

David Hart

Β 

Walbrook PR Ltd Tel: 020 7933 8780

Paul Cornelius plasticscapital@walbrookpr.com

Helen Cresswell

Β 

Β 

Notes to Editor

Plastics Capital is a niche manufacturer of specialist plastic products. Applications for these products vary widely and examples include:

β€’ Packaging for the food manufacturing and distribution - films, sacks and pouches

β€’ Steering columns and instrument control knobs in the automotive industry - plastic ball bearings

β€’ Hydraulic and industrial rubber hose manufacture - various types of plastic mandrel

β€’ Cardboard box manufacture - plastic creasing matrices

Β 

Plastics Capital's business model is based on understanding customers' problems in depth, and then developing and mass producing proprietary, technical solutions for these problems.

Β 

The business operates through two divisions, Films and Industrial, and has the majority of its production in five UK based factories, with a further three factories in Asia. Approximately 40% of its Β£55 million sales are made outside the UK to more than 80 countries.

Further information can be found on www.plasticscapital.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFSDFFIFLID
Date   Source Headline
3rd Sep 201911:55 amRNSForm 8.3 - Synnovia PLC
3rd Sep 201911:14 amGNWForm 8.3 - Synnovia plc
3rd Sep 20197:00 amRNSOffer by BPF1 Limited
2nd Sep 20193:33 pmRNSResult of AGM
8th Aug 20199:16 amRNSAnnual Financial Report
9th Jul 20197:00 amRNSFinal Results
3rd Jul 201910:51 amRNSNotice of Results
1st Jul 20192:48 pmRNSRefinancing of Banking Arrangements
1st Jul 20192:22 pmRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSTrading Update and Restatement of Accounts
19th Feb 20197:00 amRNSTrading Statement
20th Dec 20184:37 pmRNSDirector/PDMR Shareholding
20th Dec 201811:35 amRNSResult of General Meeting and Change of Name
20th Dec 20187:00 amRNSDirector/PDMR Shareholding
14th Dec 20182:23 pmRNSDirector/PDMR Shareholding
14th Dec 201810:35 amRNSDirector/PDMR Shareholding
5th Dec 20186:27 pmRNSDirector/PDMR Shareholding
5th Dec 201810:16 amRNSHolding(s) in Company
5th Dec 201810:12 amRNSHolding(s) in Company
3rd Dec 20187:00 amRNSHalf-year Report
16th Nov 201811:01 amRNSNotice of Results
5th Oct 20188:00 amRNSTrading Statement
28th Aug 20188:36 amRNSHolding(s) in Company
30th Jul 20182:36 pmRNSResult of AGM
25th Jul 20181:54 pmRNSDirector/PDMR Shareholding
16th Jul 20188:13 amRNSDirector/PDMR Shareholding
9th Jul 20181:46 pmRNSAnnual Financial Report
2nd Jul 20187:00 amRNSFinal Results
22nd Jun 20187:00 amRNSNotice of Results
2nd May 20187:00 amRNSTrading Update
11th Apr 201811:02 amRNSUK Investor Show
16th Mar 20182:22 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTrading Statement
6th Dec 20177:00 amRNSHalf-year Report
20th Nov 20179:38 amRNSNotice of Results
17th Nov 201710:54 amRNSHolding(s) in Company
5th Oct 20173:48 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:43 pmRNSDirector/PDMR Dealing and Issue of Equity
2nd Oct 20177:00 amRNSTrading Update
1st Aug 20173:42 pmRNSResult of AGM
12th Jul 201711:32 amRNSHolding(s) in Company
11th Jul 20179:19 amRNSHolding(s) in Company
7th Jul 20174:41 pmRNSAnnual Financial Report
3rd Jul 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSNotice of Results
8th Jun 20175:06 pmRNSHolding(s) in Company
5th Jun 20179:32 amRNSHolding(s) in Company
1st Jun 20174:28 pmRNSApplication for Admission
26th May 20177:00 amRNSPlacing to raise £3.74 million
2nd May 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.